Show Notes:

In this episode, I chat with Ben LeNail, Healthcare Investor & Consultant. 

Ben Lenail, based in Palo Alto CA, has consulted with biotech companies such as Minoryx Therapeutics, Autobahn Therapeutics, and Deep Genomics. Ben is an investor in 15 early-stage healthcare companies with HealthTech Capital. He is a mentor with the Chan Zuckerberg Initiative; and serves on the Board of ALD Connect and the Advisory Board of the UCSF Center for Vulnerable Populations.

Ben has worked in high-tech in Silicon Valley for 30+ years. He’s a graduate of the University of Washington in Seattle WA and Sciences-Po in Paris. Ben’s wife Laurie Yoler has been his partner for three decades.

Explore more!

WSJ Profile: https://www.wsj.com/articles/a-rare-disease-wont-keep-this-mountain-man-off-the-trails-11544875201

Mercury News Profile: https://www.mercurynews.com/2017/11/13/palo-alto-entrepreneur-brings-tech-savvy-to-an-illness-that-hits-home-ald/

Brain & Life Profile: https://www.brainandlife.org/articles/adrenoleukodystrophy-inspires-purpose/

See you all on Saturday!

- Shivani Vyas ☺

@raredisorderpod on IG & Twitter, The Rare Disorder Podcast on LinkedIn
https://linktr.ee/theraredisorderpodcast

---

Support this podcast: https://podcasters.spotify.com/pod/show/theraredisorderpodcast/support